Overview
What is Phare Bio Inc?
Phare Bio Inc is a Boston-based nonprofit organization, located at 303 Congress Street 2nd Floor, specializing in addressing the looming crisis of antibiotic resistance. Utilizing cutting-edge AI/deep learning technology, Phare Bio aims to rapidly discover and develop novel classes of antibiotics, targeting the deadliest pathogens. With a small workforce of just two individuals, the organization's mission is to ensure these life-saving therapies reach those in greatest need, overcoming economic challenges in the antibiotic market. By partnering with Professor Jim Collins' lab at MIT, Phare Bio leverages advanced technology to develop critically needed antibiotics, contributing to the global fight against antibiotic resistance.
Official website here: www.pharebio.org
Is Phare Bio Inc legitimate?
Phare Bio Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Phare Bio Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $650,167
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.pharebio.org
What is the mission statement of Phare Bio Inc?
Phare Bio Inc's mission is centered around combating the looming crisis of antibiotic resistance. Utilizing advanced AI and deep learning approaches, the company aims to expeditiously discover and develop novel classes of antibiotics against the deadliest pathogens. The goal is to ensure these life-saving therapies reach those in greatest need. Phare Bio has several promising early-stage pipeline projects and is conducting extensive in vitro and in vivo drug development studies. The antibiotic candidates are discovered through a unique AI/deep learning platform developed in collaboration with Professor Jim Collins' lab at MIT and optimized for future clinical application at Phare Bio. With this cutting-edge platform and a non-profit business model, Phare Bio is uniquely addressing economic challenges in the antibiotic market and developing novel classes of antibiotics.
Official website here: www.pharebio.org
Who is the CEO of Phare Bio Inc?
Akhila Kosaraju is the Ceo & President of Phare Bio Inc. The CEO's salary of Phare Bio Inc is $395,154 and their total compensation is $417,333.
Official website here: www.pharebio.org
What is the revenue of Phare Bio Inc?
Who are the executives of Phare Bio Inc and what are their salaries?
The average compensation at Phare Bio Inc during 2022 was $325,084. There are 2 employees and 6 volunteers at Phare Bio Inc.
Here are 7 key members and their salaries (Phare Bio Inc's CEO's salary is $395,154 and their total compensation is $417,333):
- Akhila Kosaraju (Ceo & President)
- William Foster (Chair & Treasurer)
- Steve Ellis (Director)
- James Collins (Director)
- Jose-Carlos Guttierez-Ramos (Director)
- Robert Plenge (Director)
- Susan Urahn (Director)
Official website here: www.pharebio.org
Where can I find the form 990 for Phare Bio Inc?
The Phare Bio Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.pharebio.org
Learn more at the official website: www.pharebio.org
Mission Statement of Phare Bio Inc
Phare Bio, a pioneering organization, is dedicated to combating the looming crisis of antibiotic resistance through innovative approaches. Utilizing advanced AI and deep learning techniques, Phare Bio's mission is to rapidly discover and develop new classes of antibiotics targeting the deadliest pathogens. Their objective is to ensure these life-saving therapies reach those in greatest need.
Professor Jim Collins' lab at MIT, Phare Bio's AI discovery partner and co-founder, has developed a novel platform for this purpose. Phare Bio leverages this technology to identify potential antibiotics and optimizes them for future clinical application. With a nonprofit business model, Phare Bio is uniquely addressing economic challenges in the antibiotic market, thereby contributing significantly to the development of novel antibiotics to combat antibiotic resistance.
Impact
This information is meant to be a general summary of Phare Bio Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
Phare Bio Inc's impact lies in its cutting-edge approach to combatting antimicrobial resistance. By utilizing AI and deep learning technologies, Phare Bio is at the forefront of developing critically needed antibiotics to address a looming crisis in antibiotic resistance. The organization's mission is to rapidly discover and develop new classes of antibiotics against the deadliest pathogens, with the ultimate goal of ensuring that these therapies reach the patients in greatest need. Through its innovative research and development process, Phare Bio is uniquely positioned to make a significant contribution to the field of medical research and potentially save countless lives affected by antibiotic-resistant infections.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2020
Phone
(617) 426-5900
Principal Officer
Akhila Kosaraju
Main Address
303 CONGRESS STREET 2ND FLOOR, BOSTON, MA, 02210
Website
www.pharebio.org
NTEE Category
Code: H99 - Medical research
If you are a representative of Phare Bio Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.